Save time and get answers to complex questions with AI chat
What are the most memorable drug brands in oral factor b inhibitors? in united statesGuselkumab loss of exclusitivy?When did risperdal constas patent expire published article?Drugpatentwatch skyrizi biologic patent analysis?Quartette side effects?
See the DrugPatentWatch profile for stiolto
No. Stiolto Respimat and Spiriva are different inhalers and are not the same drug, even though they are used for similar conditions. Stiolto Respimat contains two long-acting bronchodilators: tiotropium (a LAMA) and olodaterol (a LABA). Spiriva products contain tiotropium only (a LAMA).
Both are used in chronic obstructive pulmonary disease (COPD) to help keep airways open and reduce symptoms. Tiotropium is the shared ingredient, but Stiolto adds olodaterol, which expands coverage compared with tiotropium alone.
Because both include tiotropium, the “feel” and the general purpose can be similar (long-acting airway opening). But Stiolto’s added olodaterol changes the treatment from single-drug bronchodilation (Spiriva) to a two-drug combination (LAMA + LABA). That also means switching between them without clinician guidance may change dosing and symptom control goals.
They use the Respimat inhaler platform for Stiolto (and different Spiriva versions use different devices depending on the product). Exact dosing and device steps depend on the specific Spiriva product you mean. If you tell me which Spiriva you have (HandiHaler vs Respimat, or the exact name on the box), I can compare them more precisely.
Other Questions About Stiolto :